Gistrup, Denmark

Lars Haastrup Pedersen

This inventor holds 1 USPTO granted patent. Top assignee: Coloplast A/s. Active years: 2002.


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 62(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lars Haastrup Pedersen: Innovator in Antibacterial Compositions

Introduction

Lars Haastrup Pedersen is a notable inventor based in Gistrup, Denmark. He has made significant contributions to the field of antibacterial compositions, showcasing his innovative spirit and dedication to improving health solutions.

Latest Patents

Lars holds a patent for "Stabilized compositions having antibacterial activity." This patent describes a stabilized composition that possesses antibacterial, antiviral, and antifungal properties. The composition includes a silver compound, which is complexed with a primary, secondary, or tertiary amine. This complex is associated with one or more hydrophilic polymers, ensuring stability during sterilization while retaining its activity without causing darkening or discoloration of the dressing during storage. He has 1 patent to his name.

Career Highlights

Lars is currently employed at Coloplast A/S, a company renowned for its commitment to developing innovative healthcare solutions. His work at Coloplast has allowed him to focus on creating effective compositions that enhance patient care and safety.

Collaborations

Throughout his career, Lars has collaborated with talented individuals such as Peter Boman Samuelsen and Kim Lambertsen Larsen. These collaborations have contributed to the advancement of his research and the successful development of his patented compositions.

Conclusion

Lars Haastrup Pedersen exemplifies the spirit of innovation in the healthcare sector through his work on antibacterial compositions. His contributions are vital in the ongoing quest for effective medical solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…